sri 63072 has been researched along with 1-oleoyl-2-acetylglycerol in 1 studies
Studies (sri 63072) | Trials (sri 63072) | Recent Studies (post-2010) (sri 63072) | Studies (1-oleoyl-2-acetylglycerol) | Trials (1-oleoyl-2-acetylglycerol) | Recent Studies (post-2010) (1-oleoyl-2-acetylglycerol) |
---|---|---|---|---|---|
10 | 0 | 0 | 626 | 0 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aglietta, M; Arese, M; Bussolino, F; Camussi, G; Costamagna, C; Garbarino, G; Pescarmona, G; Sanavio, F; Silvagno, F; Soldi, R | 1 |
1 other study(ies) available for sri 63072 and 1-oleoyl-2-acetylglycerol
Article | Year |
---|---|
Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF.
Topics: Actins; Amino Acid Sequence; Antibodies; Cell Membrane; Cells, Cultured; Chromatography, Ion Exchange; Cytoskeletal Proteins; Cytosol; Diglycerides; Diterpenes; Endothelium, Vascular; Enzyme Activation; Ginkgolides; Humans; Isoenzymes; Kinetics; Lactones; Molecular Sequence Data; Naphthalenes; Peptides; Phospholipid Ethers; Platelet Activating Factor; Polycyclic Compounds; Protein Kinase C; Protein Kinase Inhibitors; Tetradecanoylphorbol Acetate; Thiazoles; Vinculin | 1994 |